Ivermectin effect in COVID-19 varies with strongyloidiasis prevalence - Medical Xpress
3/23/2022 12:00:00 AM3 years 1 month ago
by Science X staff
by Science X staff
In trials of ivermectin as a treatment for COVID-19, the relative risk of mortality varies with strongyloidiasis prevalence, according to research published online March 21 in JAMA Network Open.
In trials of ivermectin as a treatment for COVID-19, the relative risk of mortality varies with strongyloidiasis prevalence, according to research published online March 21 in JAMA Network Open. Avi… [+2309 chars]
full article...